MBL genotype and risk of invasive pneumococcal disease: a case-control study
- 1 May 2002
- journal article
- Published by Elsevier in The Lancet
- Vol. 359 (9317), 1569-1573
- https://doi.org/10.1016/s0140-6736(02)08516-1
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- Association of mannose-binding lectin gene heterogeneity with severity of lung disease and survival in cystic fibrosisJCI Insight, 1999
- Lack of Association Between Mannose-binding Lectin, Acute Otitis Media and Early Epstein-Barr Virus Infection Among Children in GreenlandScandinavian Journal of Infectious Diseases, 1999
- Reconstitution of Opsonizing Activity by Infusion of Mannan‐Binding Lectin (MBL) to MBL‐Deficient HumansScandinavian Journal of Immunology, 1998
- Pneumococci Causing Invasive Disease in Britain 1982-1990Journal of Medical Microbiology, 1998
- Mannose-binding lectin alleles in a prospectively recruited UK populationThe Lancet, 1997
- Mannose-binding protein, genetic variants and the risk of infectionQJM: An International Journal of Medicine, 1996
- Binding of mannan-binding protein to various bacterial pathogens of meningitisClinical and Experimental Immunology, 1994
- A Low Serum Concentration of Mannan‐Binding Protein is Not Associated with Serogroup B or C Meningococcal DiseaseScandinavian Journal of Immunology, 1993
- The human mannose-binding protein functions as an opsonin.The Journal of Experimental Medicine, 1989
- A human serum mannose-binding protein inhibits in vitro infection by the human immunodeficiency virus.The Journal of Experimental Medicine, 1989